InsidersTradesSigma
Follow the Pharmaron Beijing Co., Ltd. stock price and the full insider trade history of the company, a listed equity based in Hong Kong. Shares are listed on the HK market, under the supervision of HKEX. Operating in the Health Care sector, Pharmaron Beijing Co., Ltd. has logged 4 public disclosures. Market capitalisation: €43.5bn. The latest transaction was reported on 6 May 2026 (Other). Among the most active insiders: Lou Xiaoqiang. The full history is free.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Pharmaron Beijing Co., Ltd. Strong Buy (bullish), based on 12 analysts. Average price target: HK$30.74.
6Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,441 of 29,063 companies
50.3
score / 100
Value42
Quality58
FCF yld1.1%
Earn yld3.2%
EV/EBITDA17.9x
ROE10%
Gross mgn35%
Net mgn12%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 May 2026
Declarations4 total
4,450,000 sharesShareXHKGHKEX:DA20260506E00308
4,700,000 sharesShareXHKGHKEX:DA20260506E00307
11,000,000 sharesShareXHKGHKEX:DA20260430E00043
11,000,000 sharesShareXHKGHKEX:DA20260430E00044
4 of 4 declarations
About Pharmaron Beijing Co., Ltd.
Pharmaron Beijing Co., Ltd. is a company specializing in research and development services for the pharmaceutical industry. It offers integrated solutions ranging from drug discovery to manufacturing.